Caterpillar stock sees AI-driven optimism and strong demand, but slowing growth limits upside. Click here to read an analysis ...

Equal pay laws don’t care what candidates “ask for.” Employers must set fair ranges, otherwise, expect lawsuits.

Chipmaker Nvidia ($NVDA) has surged 84% in under four months to briefly reclaim its position as the world’s most valuable ...

Investing.com - Goldman Sachs (NYSE: GS) has resumed coverage on Rhythm Pharmaceuticals (NASDAQ: RYTM) with a Buy rating and a price target of $97.00. The stock, currently trading at $89, has shown ...

Investing.com - Goldman Sachs (NYSE:GS) has resumed coverage of Halozyme Therapeutics (NASDAQ:HALO) with a Neutral rating and a $55.00 price target. The company, which has achieved a perfect Piotroski ...

Investing.com - Goldman Sachs resumed coverage on Avidity Biosciences (NASDAQ:RNA) with a Buy rating and a $55.00 price target on Thursday. According to InvestingPro data, this target aligns with ...

Analyst Ratings Published 07/10/2025, 03:12 AM 0 Goldman Sachs resumes Amylyx stock coverage with Buy rating on avexitide potential AMLX 0.00% ...

Antara Dave, a senior product designer, landed her dream job at Microsoft the second time she applied. Here's the resume she used.

Bitcoin rally potential strengthens as inflation cools and trade tensions ease, with economic factors favoring cryptocurrency growth.

AI demand is aiding the energy sector, particularly benefiting independent power producers like Constellation Energy, Vistra, and NRG Energy.

See more examples of Analyst in action. Researcher and Analyst will start rolling out to customers with a Microsoft 365 Copilot license in April as part of a new “Frontier” program that gives ...